CA2570322A1 - Side-chain crystallizable polymers for medical applications - Google Patents
Side-chain crystallizable polymers for medical applications Download PDFInfo
- Publication number
- CA2570322A1 CA2570322A1 CA002570322A CA2570322A CA2570322A1 CA 2570322 A1 CA2570322 A1 CA 2570322A1 CA 002570322 A CA002570322 A CA 002570322A CA 2570322 A CA2570322 A CA 2570322A CA 2570322 A1 CA2570322 A1 CA 2570322A1
- Authority
- CA
- Canada
- Prior art keywords
- polymer
- medical device
- group
- polymeric material
- crystallizable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
- C08G64/04—Aromatic polycarbonates
- C08G64/06—Aromatic polycarbonates not containing aliphatic unsaturation
- C08G64/08—Aromatic polycarbonates not containing aliphatic unsaturation containing atoms other than carbon, hydrogen or oxygen
- C08G64/10—Aromatic polycarbonates not containing aliphatic unsaturation containing atoms other than carbon, hydrogen or oxygen containing halogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/12036—Type of occlusion partial occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/12145—Coils or wires having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/12186—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices liquid materials adapted to be injected
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0442—Polymeric X-ray contrast-enhancing agent comprising a halogenated group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0476—Particles, beads, capsules, spheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0042—Materials resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/18—Materials at least partially X-ray or laser opaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/12—Esters of monohydric alcohols or phenols
- C08F220/16—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
- C08F220/18—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
- C08F220/1818—C13or longer chain (meth)acrylate, e.g. stearyl (meth)acrylate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
- C08G63/682—Polyesters containing atoms other than carbon, hydrogen and oxygen containing halogens
- C08G63/6824—Polyesters containing atoms other than carbon, hydrogen and oxygen containing halogens derived from polycarboxylic acids and polyhydroxy compounds
- C08G63/6826—Dicarboxylic acids and dihydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
- C08G63/685—Polyesters containing atoms other than carbon, hydrogen and oxygen containing nitrogen
- C08G63/6854—Polyesters containing atoms other than carbon, hydrogen and oxygen containing nitrogen derived from polycarboxylic acids and polyhydroxy compounds
- C08G63/6856—Dicarboxylic acids and dihydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
- C08G63/688—Polyesters containing atoms other than carbon, hydrogen and oxygen containing sulfur
- C08G63/6884—Polyesters containing atoms other than carbon, hydrogen and oxygen containing sulfur derived from polycarboxylic acids and polyhydroxy compounds
- C08G63/6886—Dicarboxylic acids and dihydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/91—Polymers modified by chemical after-treatment
- C08G63/914—Polymers modified by chemical after-treatment derived from polycarboxylic acids and polyhydroxy compounds
- C08G63/916—Dicarboxylic acids and dihydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
- C08G64/04—Aromatic polycarbonates
- C08G64/06—Aromatic polycarbonates not containing aliphatic unsaturation
- C08G64/08—Aromatic polycarbonates not containing aliphatic unsaturation containing atoms other than carbon, hydrogen or oxygen
- C08G64/12—Aromatic polycarbonates not containing aliphatic unsaturation containing atoms other than carbon, hydrogen or oxygen containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
- C08G64/42—Chemical after-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
- C08G65/38—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives derived from phenols
- C08G65/40—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives derived from phenols from phenols (I) and other compounds (II), e.g. OH-Ar-OH + X-Ar-X, where X is halogen atom, i.e. leaving group
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/04—Polysiloxanes
- C08G77/22—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen
- C08G77/24—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen halogen-containing groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2261/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
- C08G2261/10—Definition of the polymer structure
- C08G2261/12—Copolymers
- C08G2261/126—Copolymers block
Abstract
Inherently radiopaque side-chain crystallizable polymers (IRSCCP's) are useful in various medical applications. An example of a IRSCCP is a polymer that comprises a main chain, a plurality of crystallizable side chains, and a plurality of heavy atoms attached to the polymer, the heavy atoms being present in an amount that is effective to render the polymer radiopaque. A
polymeric material that includes a IRSCCP may be fabricated into a medical device useful for at least partially occluding a body cavity. For example, such a medical device may be an embolotherapy product.
polymeric material that includes a IRSCCP may be fabricated into a medical device useful for at least partially occluding a body cavity. For example, such a medical device may be an embolotherapy product.
Claims (75)
1. A polymer comprising:
a main chain;
a plurality of crystallizable side chains; and a plurality of heavy atoms attached to the polymer, the heavy atoms being present in an amount that is effective to render the polymer radiopaque.
a main chain;
a plurality of crystallizable side chains; and a plurality of heavy atoms attached to the polymer, the heavy atoms being present in an amount that is effective to render the polymer radiopaque.
2. The polymer of Claim 1 having a melting point in the range of about 30°C to about 80°C.
3. The polymer of Claim 1 that is biocompatible.
4. The polymer of Claim 1 that is bioresorbable.
5. The polymer of Claim 1 in which the plurality of heavy atoms comprise an atom having an atomic number of at least 17.
6. The polymer of Claim 5 in which the plurality of heavy atoms comprise an atom having an atomic number of at least 35.
7. The polymer of Claim 1 in which the plurality of heavy atoms comprise an atom selected from the group consisting of bromine, iodine, bismuth, gold, platinum tantalum, tungsten, and barium.
8. The polymer of Claim 1 in which the plurality of heavy atoms are covalently attached to the polymer.
9. The polymer of Claim 1 in which the plurality of heavy atoms are ionically attached to the polymer.
10. The polymer of Claim 1 that is a copolymer comprising at least two different recurring units.
11. The polymer of Claim 10 that is a random copolymer.
12. The polymer of Claim 10 that is a block copolymer.
13. The polymer of Claim 1 in which the heavy atoms are attached to the polymer in a manner that minimizes disruption of side chain crystallinity.
14. The polymer of Claim 1 that comprises a recurring unit of the formula (I):
(I) wherein:
X1 and X2 are each independently selected from the group consisting of Br and I;
y1 and y2 are each independently zero or an integer in the range of 1 to 4;
A1 is selected from the group consisting of R3 is selected from the group consisting of C1-C30 alkyl, C1-C30 heteroalkyl, C5-C30 aryl, C6-C30 alkylaryl, and C2-C30 heteroaryl;
R4 selected from the group consisting of H, C1-C30 alkyl, and C1-C30 heteroalkyl;
R1 is Z is O or S;
R5 and R6 are each independently selected from the group consisting of -CH=CH-, -CHJ1-CHJ2-, and -(CH2)n-;
a is zero or an integer in the range of 1 to 8;
J1 and J2 are each independently selected from the group consisting of Br and I; and Q is a crystallizable group comprising from about 6 to about 30 carbon atoms.
(I) wherein:
X1 and X2 are each independently selected from the group consisting of Br and I;
y1 and y2 are each independently zero or an integer in the range of 1 to 4;
A1 is selected from the group consisting of R3 is selected from the group consisting of C1-C30 alkyl, C1-C30 heteroalkyl, C5-C30 aryl, C6-C30 alkylaryl, and C2-C30 heteroaryl;
R4 selected from the group consisting of H, C1-C30 alkyl, and C1-C30 heteroalkyl;
R1 is Z is O or S;
R5 and R6 are each independently selected from the group consisting of -CH=CH-, -CHJ1-CHJ2-, and -(CH2)n-;
a is zero or an integer in the range of 1 to 8;
J1 and J2 are each independently selected from the group consisting of Br and I; and Q is a crystallizable group comprising from about 6 to about 30 carbon atoms.
15. The polymer of Claim 14 in which Q comprises from about 20 to about 30 carbon atoms.
16. The polymer of Claim 14 in which R5 is -CH=CH- or -(CH2)n-; R6 is -(CH2)a-; and Q is an ester group comprising from about 10 to about 30 carbon atoms.
17. The polymer of Claim 1 that comprises a recurring unit of the formula (II):
wherein R7 is H or CH3; A3 is a chemical group having a molecular weight of about 500 or less; and A3 bears at least one of the heavy atoms attached to the polymer.
wherein R7 is H or CH3; A3 is a chemical group having a molecular weight of about 500 or less; and A3 bears at least one of the heavy atoms attached to the polymer.
18. The polymer of Claim 17 in which A3 comprises a metal carboxylate or metal sulfonate.
19. The polymer of Claim 18 in which A3 comprises barium.
20. The polymer of Claim 17 in which A3 comprises an ester or amide linkage.
21. The polymer of Claim 17 in which A3 comprises an aromatic group bearing at least one halogen atom selected from the group consisting of bromine and iodine.
22. The polymer of Claim 17 in which A3 comprises a chemical group of the formula -L1-(CH2)n2-L2-Ar1, wherein L1 and L2 each independently represent a nullity, ester, ether or amide group; n2 is zero or an integer in the range of about 1 to about 30; and Ar1 comprises a halogenated aromatic group containing from about 2 to about 20 carbon atoms.
23. The polymer of Claim 17 that comprises a second recurring unit, the second recurring unit comprising at least one of the crystallizable side chains.
24. The polymer of Claim 23 in which the second recurring unit is of the formula (III):
wherein R8 is H or CH3; L3 is an ester or amide linkage; and R9 comprises a C6 to C30 hydrocarbon group.
wherein R8 is H or CH3; L3 is an ester or amide linkage; and R9 comprises a C6 to C30 hydrocarbon group.
25. The polymer of Claim 1 that comprises a recurring unit of the formula (IV):
wherein A4 represents H or a chemical group containing from about 1 to about 30 carbons; A3 is a chemical group having a molecular weight of about 500 or less; and A3 bears at least one of the heavy atoms attached to the polymer.
wherein A4 represents H or a chemical group containing from about 1 to about 30 carbons; A3 is a chemical group having a molecular weight of about 500 or less; and A3 bears at least one of the heavy atoms attached to the polymer.
26. The polymer of Claim 25 in which A3 comprises an aromatic group bearing it least one halogen atom selected from the group consisting of bromine and iodine.
27. The polymer of Claim 25 that comprises a second recurring unit, the second recurring unit comprising at least one of the crystallizable side chains.
28. The polymer of Claim 27 in which the second recurring unit is of the formula (V):
wherein R10 comprises a C6 to C30 hydrocarbon group and R11 represents H
or a C1 to C30 hydrocarbon group.
wherein R10 comprises a C6 to C30 hydrocarbon group and R11 represents H
or a C1 to C30 hydrocarbon group.
29. A medical device that comprises the polymer of Claim 1.
30. The medical device of Claim 29 that further comprises an effective amount of at least one therapeutic agent.
31. A medical device that comprises a polymeric material, the polymeric material comprising a biocompatible inherently radiopaque side chain crystallizable polymer.
32. The medical device of Claim 31 in which the polymeric material comprises a second polymer in admixture with the inherently radiopaque polymer.
33. The medical device of Claim 31 in which the inherently radiopaque polymer is bioresorbable.
34. The medical device of Claim 31 that is configured to be deliverable to a body cavity of a mammal.
35. The medical device of Claim 34 that is configured to be deliverable by injection or by catheter.
36. The medical device of Claim 34 that comprises an embolotherapy product, the embolotherapy product comprising at least a portion of the inherently radiopaque polymer.
37. The medical device of Claim 36 in which at least a portion of the inherently radiopaque polymer in the embolotherapy product is formed into at least one configuration selected from the group consisting of a rod, a particle, or a sheet.
38. The medical device of Claim 37 in which the rod is in the form of a coil.
39. The medical device of Claim 38 in which the coil is a memory coil.
40. The medical device of Claim 37 in which the particle is selected from the group consisting of a spherical particle, a geometrically non-uniform particle, a porous particle, a hollow particle, a solid particle, and a particle having an excluded diameter of from about 10 microns to about 5,000 microns.
41. The medical device of Claim 40 in which the geometrically non-uniform particle is a flake or a chip.
42. The medical device of Claim 34 in which the polymeric material has a melting point in the range of about 30°C to about 80°C.
43. The medical device of Claim 42 in which the polymeric material is configured to flow at a temperature above the melting point.
44. The medical device of Claim 43 in which the polymeric material has a viscosity in the range of about 50 cP to about 500 cP at the temperature above the melting point.
45. The medical device of Claim 43 in which the polymeric material has a viscosity in the range of about 500 cP to about 5,000 cP at the temperature above the melting point.
46. The medical device of Claim 43 in which the polymeric material has a viscosity in the range of about 5,000 cP to about 250,000 cP at the temperature above the melting point.
47. The medical device of Claim 43 in which the polymeric material has a viscosity in the range of about 250,000 cP to about 1,000,000 cP at the temperature above the melting point.
48. The medical device of Claim 43 in which the polymeric material comprises a crystalline region and a non-crystalline region at a temperature below the body temperature of the mammal.
49. The medical device of Claim 48 in which the non-crystalline region has a glass transition temperature that is higher than the body temperature.
50. The medical device of Claim 48 in which the non-crystalline region has a glass transition temperature that is lower than the body temperature.
51. The medical device of Claim 43 in which the polymeric material is configured to form a solid mass upon delivery to the body cavity, the solid mass at least partically conforming to an interior dimension of the body cavity.
52. The medical device of Claim 51 in which the polymeric material comprises an excipient selected from the group consisting of a photopolymerizable material, a blood reactive substance and a nucleating agent.
53. The medical device of Claim 51 in which the solid mass retains a preformed shape.
54. The medical device of Claim 53 in which the preformed shape is a coil.
55. The medical device of Claim 31 that further comprises an effective amount of at least one therapeutic agent.
56. The medical device of Claim 55 in which the therapeutic agent is selected from the group consisting of a chemotherapeutic agent, a non-steroidal anti-inflammatory, a steroidal anti-inflammatory, and a wound healing agent.
57. The medical device of Claim 55 in which the therapeutic agent is selected to promote at least one biological response.
58. The medical device of Claim 57 in which the biological response is selected from the group consisting of thrombosis, cell attachment, cell proliferation, attraction of inflammatory cells, deposition of matrix proteins, inhibition of thrombosis, inhibition of cell attachment, inhibition of cell proliferation, inhibition of inflammatory cells, and inhibition of deposition of matrix proteins.
59. The medical device of Claim 55 in which at least a portion of the therapeutic agent is contained within the polymeric material.
60. The medical device of Claim 59 in which at least a portion of the therapeutic agent is releasable from the polymeric material upon heating.
61. The medical device of Claim 31 that further comprises an effective amount of at least one magnetic resonance enhancing agent.
62. A method of treatment comprising introducing a medical device into a body cavity of a mammal in an amount that is effective to at least partially occlude the body cavity, wherein the medical device comprises a polymeric material, and wherein the polymeric material comprises a biocompatible inherently radiopaque side chain crystallizable polymer.
63. The method of Claim 62 in which the body cavity is selected from the group consisting of a tube, a tubule, a duct, a channel, a foramen, a vessel, a void, and a canal.
64. The method of Claim 62 in which the polymeric material has a melting point in the range of about 30°C to about 80°C.
65. The method of Claim 64 in which introducing the medical device into the body cavity comprises heating the polymeric material to a temperature that is higher than the melting point.
66. The method of Claim 65 in which introducing the medical device into the body cavity comprises cooling the polymeric material to a temperature that is lower than the melting point.
67. The method of Claim 66 in which the body cavity is a blood vessel.
68. The method of Claim 67 in which the blood vessel is a varicose vein.
69. The method of Claim 67 in which introducing the medical device into the blood vessel comprises flowing the polymeric material through a catheter, a syringe, a nozzle or combination thereof.
70. A method for making an inherently radiopaque side chain crystallizable polymer, comprising copolymerizing a first monomer and a second monomer, the first monomer comprising a heavy atom and the second monomer comprising a crystallizable group.
71. The method of Claim 70 in which the heavy atom is selected from the group consisting of bromine and iodine.
72. The method of Claim 70 in which the crystallizable group comprises from about 6 to about 30 carbon atoms.
73. A method for making an inherently radiopaque side chain crystallizable polymer, comprising reacting a side chain crystallizable polymer with a heavy metal reagent under conditions selected to attach a plurality of heavy atoms to the side chain crystallizable polymer.
74. The method of Claim 73 in which the heavy metal reagent comprises bromine.
75. The method of Claim 73 in which the heavy metal reagent comprises iodine.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58679604P | 2004-07-08 | 2004-07-08 | |
US60/586,796 | 2004-07-08 | ||
PCT/US2005/024289 WO2006014596A1 (en) | 2004-07-08 | 2005-07-07 | Side-chain crystallizable polymers for medical applications |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2570322A1 true CA2570322A1 (en) | 2006-02-09 |
CA2570322C CA2570322C (en) | 2010-06-29 |
Family
ID=35311439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2570322A Active CA2570322C (en) | 2004-07-08 | 2005-07-07 | Side-chain crystallizable polymers for medical applications |
Country Status (9)
Country | Link |
---|---|
US (3) | US7939611B2 (en) |
EP (1) | EP1776407B1 (en) |
JP (1) | JP5107706B2 (en) |
CN (1) | CN1997686B (en) |
AU (1) | AU2005269868B2 (en) |
CA (1) | CA2570322C (en) |
HK (1) | HK1104831A1 (en) |
RU (1) | RU2383558C2 (en) |
WO (1) | WO2006014596A1 (en) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6623521B2 (en) | 1998-02-17 | 2003-09-23 | Md3, Inc. | Expandable stent with sliding and locking radial elements |
US20070142901A1 (en) * | 1998-02-17 | 2007-06-21 | Steinke Thomas A | Expandable stent with sliding and locking radial elements |
US7700819B2 (en) | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
US7763769B2 (en) * | 2001-02-16 | 2010-07-27 | Kci Licensing, Inc. | Biocompatible wound dressing |
AU2003270070A1 (en) * | 2002-09-04 | 2004-03-29 | Reva Medical, Inc. | A slide and lock stent and method of manufacture from a single piece shape |
WO2005030268A1 (en) | 2003-09-25 | 2005-04-07 | Rutgers, The State University | Inherently radiopaque polymeric products for embolotherapy |
US8703113B2 (en) | 2004-07-08 | 2014-04-22 | Reva Medical Inc. | Side-chain crystallizable polymers for medical applications |
AU2005269868B2 (en) | 2004-07-08 | 2008-10-23 | Reva Medical, Inc. | Side-chain crystallizable polymers for medical applications |
US8702716B1 (en) | 2009-09-21 | 2014-04-22 | Reva Medical Inc. | Devices, compositions and methods for bone and tissue augmentation |
US7763065B2 (en) | 2004-07-21 | 2010-07-27 | Reva Medical, Inc. | Balloon expandable crush-recoverable stent device |
US20060034769A1 (en) * | 2004-08-13 | 2006-02-16 | Rutgers, The State University | Radiopaque polymeric stents |
RU2396289C2 (en) | 2004-08-13 | 2010-08-10 | Рева Медикал, Инк. | Multi-purpose bioresorbable, inherently radio-opaque polymers |
US8292944B2 (en) | 2004-12-17 | 2012-10-23 | Reva Medical, Inc. | Slide-and-lock stent |
US7914574B2 (en) * | 2005-08-02 | 2011-03-29 | Reva Medical, Inc. | Axially nested slide and lock expandable device |
US9149378B2 (en) | 2005-08-02 | 2015-10-06 | Reva Medical, Inc. | Axially nested slide and lock expandable device |
US8235939B2 (en) * | 2006-02-06 | 2012-08-07 | Kci Licensing, Inc. | System and method for purging a reduced pressure apparatus during the administration of reduced pressure treatment |
US8267918B2 (en) * | 2006-03-14 | 2012-09-18 | Kci Licensing, Inc. | System and method for percutaneously administering reduced pressure treatment using a flowable manifold |
US9456860B2 (en) * | 2006-03-14 | 2016-10-04 | Kci Licensing, Inc. | Bioresorbable foaming tissue dressing |
CN101415449A (en) * | 2006-04-06 | 2009-04-22 | 雷瓦医药公司 | Embolism prosthesis for treating vas aneurysm |
US8507639B2 (en) * | 2006-09-11 | 2013-08-13 | Boston Scientific Scimed, Inc. | Radiopaque amide polymers and medical devices formed thereof |
JP5165686B2 (en) | 2006-10-17 | 2013-03-21 | ラトガース,ザ ステート ユニバーシティ | N-substituted monomers and polymers |
US7704275B2 (en) | 2007-01-26 | 2010-04-27 | Reva Medical, Inc. | Circumferentially nested expandable device |
EP1992371A1 (en) * | 2007-05-15 | 2008-11-19 | Occlutech GmbH | Bio reabsorbable polymer materials opaque to X-rays and occlusion instruments made thereof |
JP5216098B2 (en) | 2007-11-30 | 2013-06-19 | レヴァ メディカル、 インコーポレイテッド | Axial and radially nested expandable device |
EP2331014B1 (en) | 2008-10-10 | 2017-08-09 | Reva Medical, Inc. | Expandable slide and lock stent |
CA2737763C (en) | 2008-10-11 | 2019-04-09 | Rutgers, The State University Of New Jersey | Phase-separated biocompatible polymer compositions for medical uses |
US20100137908A1 (en) * | 2008-12-01 | 2010-06-03 | Zimmer Spine, Inc. | Dynamic Stabilization System Components Including Readily Visualized Polymeric Compositions |
RU2011127674A (en) * | 2008-12-31 | 2013-02-10 | КейСиАй ЛАЙСЕНЗИНГ, ИНК. | HIGHWAYS, SYSTEMS AND METHODS FOR APPLYING THE REDUCED PRESSURE TO THE SUBSTANCE OF THE SUBCUTANEOUS TISSUE |
EP2459638B1 (en) | 2009-07-31 | 2017-09-27 | Rutgers, The State University of New Jersey | Monomers and phase-separated biocompatible polymer compositions prepared therefrom for medical uses |
EP2486081B1 (en) | 2009-10-11 | 2018-12-05 | Rutgers, The State University of New Jersey | Biocompatible polymers for medial devices |
US20110086001A1 (en) * | 2009-10-11 | 2011-04-14 | Rutgers University | Compliant biocompatible polymer compositions for medical uses |
WO2011127452A1 (en) | 2010-04-10 | 2011-10-13 | Reva Medical, Inc | Expandable slide and lock stent |
WO2012019145A1 (en) | 2010-08-06 | 2012-02-09 | Endoshape, Inc. | Radiopaque shape memory polymers for medical devices |
JP2012180497A (en) * | 2011-02-08 | 2012-09-20 | Kaneka Corp | Highly thermoconductive thermoplastic resin composition |
US11472918B2 (en) | 2012-02-03 | 2022-10-18 | Rutgers, The State University Of New Jersey | Polymeric biomaterials derived from phenolic monomers and their medical uses |
JP6182159B2 (en) | 2012-02-03 | 2017-08-16 | ラトガース,ザ ステート ユニバーシティ オブ ニュー ジャージー | Polymeric biomaterials derived from phenolic monomers and their medical applications |
WO2014124225A1 (en) | 2013-02-08 | 2014-08-14 | Endoshape, Inc. | Radiopaque polymers for medical devices |
US9408732B2 (en) | 2013-03-14 | 2016-08-09 | Reva Medical, Inc. | Reduced-profile slide and lock stent |
JP6543831B2 (en) | 2013-03-15 | 2019-07-17 | エンドゥーシェイプ インコーポレイテッド | Polymer composition having enhanced radiopacity |
WO2015021254A1 (en) | 2013-08-07 | 2015-02-12 | Rutgers, The State Universtity Of New Jersey | Polymeric biomaterials derived from monomers comprising hydroxyacids and phenol compounds and their medical uses |
CN106103613B (en) * | 2014-03-10 | 2019-07-09 | 3M创新有限公司 | Conformal coating composition |
AU2015370426B2 (en) * | 2014-12-23 | 2019-09-12 | Rutgers, The State University Of New Jersey | Biocompatible iodinated diphenol monomers and polymers |
US10774030B2 (en) | 2014-12-23 | 2020-09-15 | Rutgers, The State University Of New Jersey | Polymeric biomaterials derived from phenolic monomers and their medical uses |
WO2018102714A1 (en) | 2016-12-02 | 2018-06-07 | Endoshape, Inc. | Radiopaque polymers with enhanced radiopacity |
US11223722B1 (en) * | 2020-12-23 | 2022-01-11 | AcqueonTechnologies Inc. | System and method for unified autodial campaign management |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE348111B (en) | 1967-11-16 | 1972-08-28 | Pharmacia Ab | |
US4638045A (en) | 1985-02-19 | 1987-01-20 | Massachusetts Institute Of Technology | Non-peptide polyamino acid bioerodible polymers |
US4863735A (en) | 1985-02-19 | 1989-09-05 | Massachusetts Institute Of Technology | Biodegradable polymeric drug delivery system with adjuvant activity |
JPS6234101A (en) | 1985-08-08 | 1987-02-14 | Toray Ind Inc | Plastic lens having high refractive index |
EP0266775A3 (en) | 1986-11-07 | 1989-11-08 | Showa Denko Kabushiki Kaisha | Laminates |
US4980449A (en) * | 1988-07-14 | 1990-12-25 | Rutgers, The State University | Polyiminocarbonate synthesis |
US5587507A (en) * | 1995-03-31 | 1996-12-24 | Rutgers, The State University | Synthesis of tyrosine derived diphenol monomers |
US5198507A (en) | 1990-06-12 | 1993-03-30 | Rutgers, The State University Of New Jersey | Synthesis of amino acid-derived bioerodible polymers |
US5163952A (en) | 1990-09-14 | 1992-11-17 | Michael Froix | Expandable polymeric stent with memory and delivery apparatus and method |
US5613952A (en) * | 1991-12-23 | 1997-03-25 | Syringe Develpoment Partners | Safety syringe |
US5469867A (en) | 1992-09-02 | 1995-11-28 | Landec Corporation | Cast-in place thermoplastic channel occluder |
US5466439A (en) | 1992-11-12 | 1995-11-14 | Magnetic Research, Inc. | Polymeric contrast enhancing agents for magnetic resonance images |
JPH0727766A (en) | 1993-06-24 | 1995-01-31 | Eiken Chem Co Ltd | Reagent-bonded polymer and its preparation |
US5443477A (en) | 1994-02-10 | 1995-08-22 | Stentco, Inc. | Apparatus and method for deployment of radially expandable stents by a mechanical linkage |
JP3472340B2 (en) * | 1994-05-09 | 2003-12-02 | 鐘淵化学工業株式会社 | Curable composition |
US6831116B2 (en) | 1995-03-07 | 2004-12-14 | Landec Corporation | Polymeric modifying agents |
US5674242A (en) | 1995-06-06 | 1997-10-07 | Quanam Medical Corporation | Endoprosthetic device with therapeutic compound |
US6319492B1 (en) | 1996-11-27 | 2001-11-20 | Rutgers, The State University | Copolymers of tyrosine-based polyarylates and poly(alkylene oxides) |
JP4410857B2 (en) * | 1997-02-18 | 2010-02-03 | ラットガーズ ザ ステイト ユニヴァーシティ | Monomers derived from hydroxy acids and polymers prepared therefrom |
JPH10259298A (en) | 1997-03-21 | 1998-09-29 | Mitsubishi Eng Plast Kk | Polycarbonate resin composition |
US5912225A (en) * | 1997-04-14 | 1999-06-15 | Johns Hopkins Univ. School Of Medicine | Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same |
DE69842217D1 (en) * | 1997-11-07 | 2011-05-19 | State University | Radiopaque polymeric biomaterials |
EP0930343A3 (en) | 1998-01-16 | 2000-05-31 | Landec Corporation | Low profile additives for crosslink resins |
US6492462B2 (en) | 1998-01-16 | 2002-12-10 | Landec Corporation | Side chain crystalline polymer as rheology modifier for crosslinked polymer |
US6623521B2 (en) | 1998-02-17 | 2003-09-23 | Md3, Inc. | Expandable stent with sliding and locking radial elements |
DK1062278T3 (en) | 1998-02-23 | 2006-09-25 | Mnemoscience Gmbh | Polymers with shape memory |
US6015424A (en) | 1998-04-28 | 2000-01-18 | Microvention, Inc. | Apparatus and method for vascular embolization |
US6273909B1 (en) | 1998-10-05 | 2001-08-14 | Teramed Inc. | Endovascular graft system |
US6200338B1 (en) | 1998-12-31 | 2001-03-13 | Ethicon, Inc. | Enhanced radiopacity of peripheral and central catheter tubing |
US6599448B1 (en) | 2000-05-10 | 2003-07-29 | Hydromer, Inc. | Radio-opaque polymeric compositions |
US6550480B2 (en) | 2001-01-31 | 2003-04-22 | Numed/Tech Llc | Lumen occluders made from thermodynamic materials |
US6976106B2 (en) * | 2002-11-01 | 2005-12-13 | Sonics, Inc. | Method and apparatus for speculative response arbitration to improve system latency |
US7455687B2 (en) | 2002-12-30 | 2008-11-25 | Advanced Cardiovascular Systems, Inc. | Polymer link hybrid stent |
US6932930B2 (en) | 2003-03-10 | 2005-08-23 | Synecor, Llc | Intraluminal prostheses having polymeric material with selectively modified crystallinity and methods of making same |
CA2527976C (en) | 2003-06-13 | 2011-11-22 | Mnemoscience Gmbh | Stents |
WO2005030268A1 (en) | 2003-09-25 | 2005-04-07 | Rutgers, The State University | Inherently radiopaque polymeric products for embolotherapy |
AU2005269868B2 (en) * | 2004-07-08 | 2008-10-23 | Reva Medical, Inc. | Side-chain crystallizable polymers for medical applications |
RU2396289C2 (en) * | 2004-08-13 | 2010-08-10 | Рева Медикал, Инк. | Multi-purpose bioresorbable, inherently radio-opaque polymers |
-
2005
- 2005-07-07 AU AU2005269868A patent/AU2005269868B2/en active Active
- 2005-07-07 RU RU2007104489/04A patent/RU2383558C2/en not_active IP Right Cessation
- 2005-07-07 US US11/176,638 patent/US7939611B2/en active Active
- 2005-07-07 CA CA2570322A patent/CA2570322C/en active Active
- 2005-07-07 WO PCT/US2005/024289 patent/WO2006014596A1/en active Application Filing
- 2005-07-07 JP JP2007520544A patent/JP5107706B2/en active Active
- 2005-07-07 EP EP05770692.1A patent/EP1776407B1/en active Active
- 2005-07-07 CN CN2005800223795A patent/CN1997686B/en active Active
-
2007
- 2007-12-03 HK HK07113187.9A patent/HK1104831A1/en unknown
-
2011
- 2011-05-05 US US13/101,499 patent/US8133959B2/en active Active
- 2011-05-05 US US13/101,504 patent/US8124700B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2008506019A (en) | 2008-02-28 |
US20060024266A1 (en) | 2006-02-02 |
CA2570322C (en) | 2010-06-29 |
US20110212050A1 (en) | 2011-09-01 |
AU2005269868B2 (en) | 2008-10-23 |
HK1104831A1 (en) | 2008-01-25 |
CN1997686A (en) | 2007-07-11 |
WO2006014596A1 (en) | 2006-02-09 |
JP5107706B2 (en) | 2012-12-26 |
RU2383558C2 (en) | 2010-03-10 |
RU2007104489A (en) | 2008-08-27 |
CN1997686B (en) | 2010-06-30 |
EP1776407A1 (en) | 2007-04-25 |
US8133959B2 (en) | 2012-03-13 |
EP1776407B1 (en) | 2019-06-12 |
AU2005269868A1 (en) | 2006-02-09 |
US20110213090A1 (en) | 2011-09-01 |
US8124700B2 (en) | 2012-02-28 |
US7939611B2 (en) | 2011-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2570322A1 (en) | Side-chain crystallizable polymers for medical applications | |
AU2011200350B2 (en) | Side-chain crystallizable polymers for medical applications | |
AU605172B2 (en) | Polyesters containing alkylene oxide blocks as drug delivery systems | |
WO1998017201A1 (en) | Methods for treating urinary incontinence in mammals | |
WO2020202210A1 (en) | A radiopaque polymeric liquid embolic system | |
WO2020098673A1 (en) | A polymer and compositions thereof | |
KR102070580B1 (en) | A temperature responsive polymeric hydrogel, preparation method thereof and drug delivery system comprising the same | |
CN108659207A (en) | The preparation method of temperature-responsive PNVCL-b-POPD block copolymers | |
Okamura et al. | Synthesis and properties of radiopaque polymer hydrogels II: copolymers of 2, 4, 6-triiodophenyl-or N-(3-carboxy-2, 4, 6-triiodophenyl)-acrylamide and p-styrene sulfonate | |
Dai et al. | Fast thermoresponsive BAB-type HEMA/NIPAAm triblock copolymer solutions for embolization of abnormal blood vessels | |
Jabbari et al. | Material properties and biocompatibility of self-crosslinkable poly (caprolactone fumarate) copolymer as a scaffold for guided tissue regeneration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |